Elrexfio
NDC 0069-2522, elranatamab-bcmm, injection, solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-2522
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761345
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-2522 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELRANATAMAB44 mg/1.1mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-2522-02 | 00069252202 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f6fea598-ff58-4a20-b5e8-8a51f37d8bebMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0069-2522
Use it
Look up 0069-2522 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-2522 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-2522. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.